Short- and long-term outcomes associated with enhanced recovery after surgery protocol vs conventional management in patients undergoing laparoscopic gastrectomy

Table 4 Postoperative morbidity and mortality

Variable	Conventional group (n = 365)	ERAS group (n = 365)	P value
Intraoperative complications, n (%)	15 (4.1)	16 (4.4)	0.854
Postoperative complications, n (%)	66 (18.1)	45 (12.3)	0.030
Wound infection, n (%)	7 (1.9)	4 (1.1)	0.546
Pulmonary, n (%)	20 (5.5)	13 (3.6)	0.212
Gastroparesis, n (%)	6 (1.6)	6 (1.6)	1.000
Anastomotic leakage, n (%)	9 (2.5)	7 (1.9)	0.613
Lymphatic leakage, n (%)	4 (1.1)	2 (0.5)	0.686
Pancreatic fistula, n (%)	2 (0.5)	1 (0.3)	1.000
Intra-abdominal bleeding, n (%)	2 (0.5)	0 (0)	0.499
Intraluminal bleeding, n (%)	5 (1.4)	5 (1.4)	1.000
Intra-abdominal abscess, n (%)	2 (0.5)	1 (0.3)	1.000
Deep vein thrombosis, n (%)	2 (0.5)	0 (0)	0.499
Ileus, n (%)	3 (0.8)	2 (0.5)	1.000
Cerebrovascular, n (%)	0 (0)	0 (0)	1.000
Cardiac, n (%)	2 (0.5)	1 (0.3)	1.000
Cholecystitis, n (%)	0 (0)	1 (0.3)	1.000
Hepatic, n (%)	1 (0.3)	1 (0.3)	1.000
Renal, n (%)	1 (0.3)	1 (0.3)	1.000
Mortality, n (%)	0 (0)	0 (0)	1.000
Clavien-Dindo classification
I, n (%)	6 (1.6)	4 (1.1)	0.752
II, n (%)	50 (13.7)	35 (9.6)	0.083
IIIa, n (%)	4 (1.1)	4 (1.1)	1.000
IIIb, n (%)	3 (0.8)	1 (0.3)	0.624
IV, n (%)	3 (0.8)	1 (0.3)	0.624

ERAS: Enhanced recovery after surgery.